Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor

Seung-Woo Cho, Joung Eun Lim, Hun Su Chu, Hye Jin Hyun, Cha Yong Choi, Ki Chul Hwang, Kyung Jong Yoo, Dong Ik Kim, Byung Soo Kim

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Successful reconstruction of large-diameter blood vessel in humans has been demonstrated using the tissue engineering technique, but improvement in patency of small-diameter bioartificial vascular graft remains a great challenge. This study reports that granulocyte colony-stimulating factor (G-CSF) can enhance in vivo endothelialization of tissue-engineered vascular grafts, which could be used to improve patency of small-diameter vascular graft. Vascular grafts were tissue engineered with decellularized canine abdominal aortas and canine autologous bone marrow-derived cells. Prior to cell seeding onto decellularized graft matrices, bone marrow-derived cells were induced to differentiate into endothelial cells and smooth muscle cells. The cell-seeded vascular grafts were implanted into the abdominal aortas of bone marrow donor dogs. Before and after graft implantation, G-CSF was administered subcutaneously to the dogs (n = 3). The grafts implanted into the dogs not receiving G-CSF were used as controls (n = 3). Eight weeks after implantation, grafts in both groups showed regeneration of vascular tissues including endothelium and smooth muscle. Importantly, endothelium formation was more extensive in the G-CSF-treated grafts than in the control grafts, as assessed with reverse transcription polymerase chain reaction, western blot, and immunohistochemistry. In addition, intimal hyperplasia was significantly reduced in the G-CSF-treated grafts compared to the control grafts. This study suggests that G-CSF administration could be applied to improve patency of small-diameter tissue-engineered vascular grafts.

Original languageEnglish
Pages (from-to)252-263
Number of pages12
JournalJournal of Biomedical Materials Research - Part A
Volume76
Issue number2
DOIs
Publication statusPublished - 2006 Feb 1

Fingerprint

Granulocyte Colony-Stimulating Factor
Grafts
Tissue
Bone
Muscle
Polymerase chain reaction
Endothelial cells
Blood vessels
Transcription
Tissue engineering

All Science Journal Classification (ASJC) codes

  • Ceramics and Composites
  • Biomaterials
  • Biomedical Engineering
  • Metals and Alloys

Cite this

Cho, Seung-Woo ; Lim, Joung Eun ; Chu, Hun Su ; Hyun, Hye Jin ; Choi, Cha Yong ; Hwang, Ki Chul ; Yoo, Kyung Jong ; Kim, Dong Ik ; Kim, Byung Soo. / Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor. In: Journal of Biomedical Materials Research - Part A. 2006 ; Vol. 76, No. 2. pp. 252-263.
@article{958115d7bb7a4cdd87fac858abe24a8c,
title = "Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor",
abstract = "Successful reconstruction of large-diameter blood vessel in humans has been demonstrated using the tissue engineering technique, but improvement in patency of small-diameter bioartificial vascular graft remains a great challenge. This study reports that granulocyte colony-stimulating factor (G-CSF) can enhance in vivo endothelialization of tissue-engineered vascular grafts, which could be used to improve patency of small-diameter vascular graft. Vascular grafts were tissue engineered with decellularized canine abdominal aortas and canine autologous bone marrow-derived cells. Prior to cell seeding onto decellularized graft matrices, bone marrow-derived cells were induced to differentiate into endothelial cells and smooth muscle cells. The cell-seeded vascular grafts were implanted into the abdominal aortas of bone marrow donor dogs. Before and after graft implantation, G-CSF was administered subcutaneously to the dogs (n = 3). The grafts implanted into the dogs not receiving G-CSF were used as controls (n = 3). Eight weeks after implantation, grafts in both groups showed regeneration of vascular tissues including endothelium and smooth muscle. Importantly, endothelium formation was more extensive in the G-CSF-treated grafts than in the control grafts, as assessed with reverse transcription polymerase chain reaction, western blot, and immunohistochemistry. In addition, intimal hyperplasia was significantly reduced in the G-CSF-treated grafts compared to the control grafts. This study suggests that G-CSF administration could be applied to improve patency of small-diameter tissue-engineered vascular grafts.",
author = "Seung-Woo Cho and Lim, {Joung Eun} and Chu, {Hun Su} and Hyun, {Hye Jin} and Choi, {Cha Yong} and Hwang, {Ki Chul} and Yoo, {Kyung Jong} and Kim, {Dong Ik} and Kim, {Byung Soo}",
year = "2006",
month = "2",
day = "1",
doi = "10.1002/jbm.a.30535",
language = "English",
volume = "76",
pages = "252--263",
journal = "Journal of Biomedical Materials Research",
issn = "1549-3296",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor. / Cho, Seung-Woo; Lim, Joung Eun; Chu, Hun Su; Hyun, Hye Jin; Choi, Cha Yong; Hwang, Ki Chul; Yoo, Kyung Jong; Kim, Dong Ik; Kim, Byung Soo.

In: Journal of Biomedical Materials Research - Part A, Vol. 76, No. 2, 01.02.2006, p. 252-263.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor

AU - Cho, Seung-Woo

AU - Lim, Joung Eun

AU - Chu, Hun Su

AU - Hyun, Hye Jin

AU - Choi, Cha Yong

AU - Hwang, Ki Chul

AU - Yoo, Kyung Jong

AU - Kim, Dong Ik

AU - Kim, Byung Soo

PY - 2006/2/1

Y1 - 2006/2/1

N2 - Successful reconstruction of large-diameter blood vessel in humans has been demonstrated using the tissue engineering technique, but improvement in patency of small-diameter bioartificial vascular graft remains a great challenge. This study reports that granulocyte colony-stimulating factor (G-CSF) can enhance in vivo endothelialization of tissue-engineered vascular grafts, which could be used to improve patency of small-diameter vascular graft. Vascular grafts were tissue engineered with decellularized canine abdominal aortas and canine autologous bone marrow-derived cells. Prior to cell seeding onto decellularized graft matrices, bone marrow-derived cells were induced to differentiate into endothelial cells and smooth muscle cells. The cell-seeded vascular grafts were implanted into the abdominal aortas of bone marrow donor dogs. Before and after graft implantation, G-CSF was administered subcutaneously to the dogs (n = 3). The grafts implanted into the dogs not receiving G-CSF were used as controls (n = 3). Eight weeks after implantation, grafts in both groups showed regeneration of vascular tissues including endothelium and smooth muscle. Importantly, endothelium formation was more extensive in the G-CSF-treated grafts than in the control grafts, as assessed with reverse transcription polymerase chain reaction, western blot, and immunohistochemistry. In addition, intimal hyperplasia was significantly reduced in the G-CSF-treated grafts compared to the control grafts. This study suggests that G-CSF administration could be applied to improve patency of small-diameter tissue-engineered vascular grafts.

AB - Successful reconstruction of large-diameter blood vessel in humans has been demonstrated using the tissue engineering technique, but improvement in patency of small-diameter bioartificial vascular graft remains a great challenge. This study reports that granulocyte colony-stimulating factor (G-CSF) can enhance in vivo endothelialization of tissue-engineered vascular grafts, which could be used to improve patency of small-diameter vascular graft. Vascular grafts were tissue engineered with decellularized canine abdominal aortas and canine autologous bone marrow-derived cells. Prior to cell seeding onto decellularized graft matrices, bone marrow-derived cells were induced to differentiate into endothelial cells and smooth muscle cells. The cell-seeded vascular grafts were implanted into the abdominal aortas of bone marrow donor dogs. Before and after graft implantation, G-CSF was administered subcutaneously to the dogs (n = 3). The grafts implanted into the dogs not receiving G-CSF were used as controls (n = 3). Eight weeks after implantation, grafts in both groups showed regeneration of vascular tissues including endothelium and smooth muscle. Importantly, endothelium formation was more extensive in the G-CSF-treated grafts than in the control grafts, as assessed with reverse transcription polymerase chain reaction, western blot, and immunohistochemistry. In addition, intimal hyperplasia was significantly reduced in the G-CSF-treated grafts compared to the control grafts. This study suggests that G-CSF administration could be applied to improve patency of small-diameter tissue-engineered vascular grafts.

UR - http://www.scopus.com/inward/record.url?scp=33645108250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645108250&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.30535

DO - 10.1002/jbm.a.30535

M3 - Article

VL - 76

SP - 252

EP - 263

JO - Journal of Biomedical Materials Research

JF - Journal of Biomedical Materials Research

SN - 1549-3296

IS - 2

ER -